Placental SEMA3B expression is not altered in severe early onset preeclampsia

TJ Kaitu'u-Lino; R Hastie; P Cannon; NK Binder; S Lee; O Stock; NJ Hannan; S Tong

Journal article

Placental SEMA3B expression is not altered in severe early onset preeclampsia

TJ Kaitu'u-Lino, R Hastie, P Cannon, NK Binder, S Lee, O Stock, NJ Hannan, S Tong

Placenta | Published : 2014

DOI: 10.1016/j.placenta.2014.10.002

Abstract

Recent evidence suggests that Semaphorin 3B (SEMA3B) is upregulated in severe preeclampsia, and a major driver of cytotrophoblast aberrations in this disease. Here we independently assess whether SEMA3B expression is altered in a large cohort of severe early onset preeclamptic placentas. We demonstrate that SEMA3B relative mRNA expression and copy number are not changed in PE placentas. We confirm this at the protein level by western blot. Interestingly, exposure of term trophoblasts or explants to hypoxia induced a significant down regulation of SEMA3B mRNA, but a trend towards increased SEMA3B protein expression. We conclude that SEMA3B mRNA and protein is not altered in severe early onset..

View full abstract

University of Melbourne Researchers

Tu'uhevaha Kaitu'u-Lino Author

Roxanne Hastie Author

Ping Cannon Author

Natalie Binder Author

Related Projects (4)

TARGETING THE TOXINS OF PREECLAMPSIA

Preeclampsia is a severe disease of pregnancy - the placenta releases toxins in to mum's bloodstream that circulate her body and damage her ..

DEVELOPING A BLOOD TEST FOR THE MOTHER TO DETERMINE WHETHER THE GROWTH RESTRICTED BABY IS UNWELL

Small babies are at greater risk of dying while inside their mothers and the right time to deliver them is an obstetric conundrum. Currently..

DEVELOPING MOLECULAR THERAPEUTICS AND DIAGNOSTICS FOR PREGNANCY COMPLICATIONS

Pregnancy complications still causes the death of mothers, and their babies. During this fellowship, we will be developing new treatments an..

Mother and baby communication during early pregnancy, the key to establishing a healthy pregnancy

Grants

Funding Acknowledgements

The National Health and Medical Research Council of Australia provided salary (#1062418 to T.K, #628927 to N.H, #1050765 to S.T.) and Scholarship Support (#1055795 to O.S.)